Additionally, and in line with these findings, lower levels of sclerostin appeared to be causally associated with higher levels of triglycerides in UK Biobank, and a higher risk of type 2 diabetes mellitus in both the meta-analysis of GWAS and our analysis of UK Biobank. Here, SOST is linked to diabetes mellitus.